Severe aortic stenosis is the most common valvular disease in the aging population of the developed world [1]. Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure that has been established as safe and effective for patients across high, intermediate, and low surgical risk categories [2]. Compared to surgical aortic valve replacement (SAVR), TAVR is associated with shorter hospital stays and lower complication rates, contributing to a steady increase in TAVR procedures…